Showing 33,241 - 33,252 results of 33,252 for search '(( 50 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( a means decrease ))', query time: 0.81s Refine Results
  1. 33241

    Table4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  2. 33242

    Image4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  3. 33243

    Table2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  4. 33244

    Transdifferentiation and <i>CYB561</i> knockdown altered the Fe<sup>2+</sup> concentrations and expression of iron responsive genes (IRGs) in LNCaP cells. by Romie Angelo G. Azur (18547651)

    Published 2024
    “…<p>LNCaP cells transduced with the scrambled (scr) shRNA control and sh<i>CYB561</i> were grown and maintained in complete media (control) or transdifferentiation media for 14 days followed by Fe<sup>2+</sup> concentration measurement. <b>(A)</b> CYB561 contributes to cellular iron homeostasis through its ferrireductase function to maintain vesicular redox states. …”
  5. 33245

    Image3_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tif by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  6. 33246

    Table2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  7. 33247

    Image1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  8. 33248

    Image4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  9. 33249

    Image1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  10. 33250

    Table4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

    Published 2022
    “…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I<sup>2</sup> = 93%). …”
  11. 33251

    Initial assessment of βHB treatment effects. by Noam H. Sander (13977976)

    Published 2024
    “…<p>A) In experiment 1, body weight was reduced on day 1 after ICH (day 1, p<0.0001), and the βHB group weighed more than the VEH group on day 1 (p = 0.0250). …”
  12. 33252

    FIGURE 6 from Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden by Maria C. White (18333517)

    Published 2024
    “…<p>NEK2 inhibition decreases tumor burden and prolongs survival in PEL xenograft mice. …”